The Ministry of Social Affairs and Health (hereinafter ”STM”) and Finnish Institute for Health and Welfare (hereinafter "THL" or “Customer” ) request your tender for Meningococcal Group B Vaccine belonging to the National Vaccination Programme in Finland.
The contract period is about two years during 2024-2025. The procurement contains two options to extend the contract for the years 2026 and 2027.
Estimated quantity for the contract period including option is 4000 doses. Customer reserves the right to increase or decrease the ordered numbers of doses by up to 20%.
The contract will be awarded to one Supplier based on a comparison of tenders. Tender that is economically the most advantageous will win the competition.
Please note that all times given in the Call for tender refer to local time in Finland.
Call for tenders, annexes:
Annex 1 Minimum Requirements Concerning the Subject of Procurement Meningococcal Group B Vaccine for risk groups
Annex 2 JYSE 2014 Supplies (updated version of April 2022)
Annex 3 Handi
Annex 4 Contract
Määräaika
Tarjousten vastaanottamisen määräaika oli 2023-05-12.
Hankinta julkaistiin 2023-03-30.
Toimittajat
Seuraavat toimittajat mainitaan hankintapäätöksissä tai muissa hankinta-asiakirjoissa:
Kohde Hankinnan laajuus
Otsikko: Meningococcal Group B Vaccine 2024-2025 (2026, 2027)
VN/5821/2022
Tuotteet/palvelut: Rokotteet📦
Lyhyt kuvaus:
“The Ministry of Social Affairs and Health (hereinafter ”STM”) and Finnish Institute for Health and Welfare (hereinafter "THL" or “Customer” ) request your...”
Lyhyt kuvaus
The Ministry of Social Affairs and Health (hereinafter ”STM”) and Finnish Institute for Health and Welfare (hereinafter "THL" or “Customer” ) request your tender for Meningococcal Group B Vaccine belonging to the National Vaccination Programme in Finland.
The contract period is about two years during 2024-2025. The procurement contains two options to extend the contract for the years 2026 and 2027.
Estimated quantity for the contract period including option is 4000 doses. Customer reserves the right to increase or decrease the ordered numbers of doses by up to 20%.
The contract will be awarded to one Supplier based on a comparison of tenders. Tender that is economically the most advantageous will win the competition.
Please note that all times given in the Call for tender refer to local time in Finland.
Call for tenders, annexes:
Annex 1 Minimum Requirements Concerning the Subject of Procurement Meningococcal Group B Vaccine for risk groups
Annex 2 JYSE 2014 Supplies (updated version of April 2022)
Annex 3 Handi
Annex 4 Contract
The purpose of STM and the Customer is to procure Meningococcal Group B Vaccine required for the National Vaccination Programme in Finland. The tendered vaccine must be suitable for adults, children and infants.
More information about National Vaccination Programme and vaccinations can be found on the website of the National Institute for Health and Welfare:
https://thl.fi/en/web/infectious-diseases-and-vaccinations/vaccines-a-to-z/meningococcal-vaccines/meningococcus-b-vaccine
The Customer will implement the procurement on behalf of STM. The roles of STM and Customer are described in more detail in section "Presentation of the contracting authority".
The subject of procurement and the mandatory requirements relating to it are described in detail in this Call for Tender and its annexes. The contract will be awarded to one Supplier based on a comparison of tenders.
CONTRACT PERIOD
The contract´s duration is about two years. Estimated quantity for the contract period is 2000 doses. The customer reserves the right to increase or decrease the ordered numbers of doses by up to 20%.
The Contract period shall enter into force once the contract has been signed, and expire when all contractual duties have been performed. After the contract period, the Customer reserves the right for the option described in section "Description of renewals".
Tenders will be compared in the manner described in section "Grounds for decision" of the Call for Tender.
Näytä lisää Myöntämisperusteet
Hinta
Sopimuksen, puitesopimuksen tai dynaamisen hankintajärjestelmän kesto
Jäljempänä oleva aikataulu on ilmaistu kuukausina.
Kuvaus
Kesto: 24
Sopimuksen, puitesopimuksen tai dynaamisen hankintajärjestelmän kesto
Tämä sopimus voidaan uusia ✅ Kuvaus
Uudistusten kuvaus:
“The procurement contains two option years (1+1) to extend the contract. Estimated quantity for each option period is 1000 doses (+/- 20%). The Customer can...”
Uudistusten kuvaus
The procurement contains two option years (1+1) to extend the contract. Estimated quantity for each option period is 1000 doses (+/- 20%). The Customer can extend the contract one or two years at a time.
Näytä lisää
Lisätietoja:
“This procurement is detailed in the contract notice published on TED (Tenders Electronic Daily) online version and on the Hilma electronic procurement...”
Lisätietoja
This procurement is detailed in the contract notice published on TED (Tenders Electronic Daily) online version and on the Hilma electronic procurement portal at www.hankintailmoitukset.fi as well as in this Call for Tenders and its Annexes.
Oikeudelliset, taloudelliset, rahoitukselliset ja tekniset tiedot Osallistumisehdot
Luettelo ja lyhyt kuvaus olosuhteista:
“Please see sections Other information of the Call for Tenders and the European Single Procurement Document (ESPD).” Taloudellinen ja rahoituksellinen asema
Hankinta-asiakirjoissa mainitut valintaperusteet
Tekninen ja ammatillinen pätevyys
Hankinta-asiakirjoissa mainitut valintaperusteet
Sopimukseen liittyvät ehdot
Sopimuksen täytäntöönpanoehdot:
“Please see sections Other information of the Call for Tenders and the European Single Procurement Document (ESPD).”
Menettely Toimenpiteen tyyppi
Avoin menettely
Hallinnolliset tiedot
Tarjousten tai osallistumishakemusten vastaanottamisen määräaika: 2023-05-12
12:00 📅
Kielet, joilla tarjoukset tai osallistumishakemukset voidaan jättää: englanti 🗣️
Jäljempänä oleva aikataulu on ilmaistu kuukausina.
Vähimmäisaika, jonka kuluessa tarjoajan on pidettävä tarjous voimassa: 6
Tarjousten avaamista koskevat ehdot: 2023-05-12
13:00 📅
Tarjousten avaamista koskevat ehdot (paikka):
“Please note that the opening of tenders an early estimate date. In addition the opening of the tenders is not a public event.
Please note that the online...”
Tarjousten avaamista koskevat ehdot (paikka)
Please note that the opening of tenders an early estimate date. In addition the opening of the tenders is not a public event.
Please note that the online connection to the Supplier Portal can be periodically slow and the download time will take time. Please fill out the tenders information in good time before the deadline expires.
Täydentävät tiedot Tietoa toistumisesta
Tämä on toistuva hankinta ✅
Arvioitu aikataulu uusien ilmoitusten julkaisemiselle:
“THL maintains an updated procurement plan at the...”
Arvioitu aikataulu uusien ilmoitusten julkaisemiselle
Näytä lisää Tietoa sähköisistä työnkuluista
Sähköistä tilaamista käytetään
Sähköinen laskutus hyväksytään
Sähköistä maksua käytetään
Lisätietoja
“Tenderers may ask clarification questions using the Supplier Portal. The questions must be in English and will be answered in English. To guarantee the...”
Tenderers may ask clarification questions using the Supplier Portal. The questions must be in English and will be answered in English. To guarantee the equal treatment of tenderers, questions posed in any other way cannot be answered.
All times given in the Call for tender refer to local time in Finland.
Ilmoitus tehdystä sopimuksesta (2023-10-03) Kohde Hankinnan laajuus
Lyhyt kuvaus:
“The Ministry of Social Affairs and Health (hereinafter ”STM”) and Finnish Institute for Health and Welfare (hereinafter "THL" or “Customer” ) requested...”
Lyhyt kuvaus
The Ministry of Social Affairs and Health (hereinafter ”STM”) and Finnish Institute for Health and Welfare (hereinafter "THL" or “Customer” ) requested tenders for Meningococcal Group B Vaccine belonging to the National Vaccination Programme in Finland.
Näytä lisää
Hankinnan kokonaisarvo (ilman arvonlisäveroa): EUR 300 000 💰
Kuvaus
Hankinnan kuvaus:
“The purpose of STM and the Customer was to procure Meningococcal Group B Vaccine required for the National Vaccination Programme in Finland. The tendered...”
Hankinnan kuvaus
The purpose of STM and the Customer was to procure Meningococcal Group B Vaccine required for the National Vaccination Programme in Finland. The tendered vaccine must be suitable for adults, children and infants.
More information about National Vaccination Programme and vaccinations can be found on the website of the National Institute for Health and Welfare:
https://thl.fi/en/web/infectious-diseases-and-vaccinations/vaccines-a-to-z/meningococcal-vaccines/meningococcus-b-vaccine
The Customer will implement the procurement on behalf of STM.
Menettely Hallinnolliset tiedot
Tätä menettelyä koskeva aiempi julkaisu: 2023/S 067-200354
Sopimuksen tekeminen
1️⃣
Sopimuksen numero: 1
Otsikko: Meningococcal Group B Vaccine 2024-2025 (2026, 2027)
Sopimuksen tekopäivä: 2023-08-29 📅
Tietoa tarjouskilpailuista
Saatujen tarjousten määrä: 1
Pk-yrityksiltä saatujen tarjousten määrä: 0
Sähköisesti vastaanotettujen tarjousten määrä: 1
Toimeksisaajan nimi ja osoite
Nimi: GlaxoSmithKline Oy
Kansallinen rekisterinumero: FI01083784
Postiosoite: Porkkalankatu 20 A
Postitoimipaikka: Helsinki
Postinumero: 00180
Maa: Suomi 🇫🇮
Alue: Suomi/Finland🏙️
Toimeksisaaja on pk-yritys
Tiedot sopimuksen/erän arvosta (ilman alv:tä)
Sopimuksen/osuuden kokonaisarvo: EUR 300 000 💰